Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?
Fernando Bril, Sameer Al Diffalha, Mark Dean et al. · Journal of Hepatology · 2021
Cited by 218 works. doi:10.1016/j.jhep.2021.04.003 Open-access PDF
Authors
References
- Guillain–Barré Syndrome Associated with SARS-CoV-2
- Thrombocytopenia following Pfizer and Moderna SARS‐CoV ‐2 vaccination
- Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases
- Immune Thrombocytopenic Purpura in a Patient with Covid-19
- Covid-19 and autoimmunity
- Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
- Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury
- Transverse myelitis and vaccines: a multi-analysis
- Drug-Induced Autoimmune Hepatitis: Response to Corticosteroids and Lack of Relapse After Cessation of Steroids
- Role of Histopathology in Autoimmune Hepatitis